These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24518026)

  • 1. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
    Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.
    Khan A; Al Balwi MA; Tanaka Y; Hajeer A; Sanai FM; Al Abdulkarim I; Al Ayyar L; Badri M; Saudi D; Tamimi W; Mizokami M; Al Knawy B
    Int J Cancer; 2013 Dec; 133(12):2864-71. PubMed ID: 23740667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
    Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
    J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B virus (HBV) mutation in enhancer I (HBV Enh I)/X-promoter and the relationship between chronic HBV-related disease spectrum].
    Deng HH; Guan YJ; Lei CL; Xu M; Hu FY; Cheng J; Li YP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):25-7. PubMed ID: 22919746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
    J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
    Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
    J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
    Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
    World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
    Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Du Y; Han X; Pu R; Xie J; Zhang Y; Cao G
    Front Med; 2014 Jun; 8(2):217-26. PubMed ID: 24748463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
    Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
    Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
    World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between metastasis or recurrence of hepatocellular carcinoma and hepatitis B virus DNA or double mutation at 1762/1764 in the basic core promoter].
    Tan YW; Zhang YH; Jiang WJ; Xing MY; Man XB; Mao JZ; Ge GH; Wu CS; Zhu MQ; Xu J; Sun L; Zhou XP
    Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):679-83. PubMed ID: 24160343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.
    Asim M; Malik A; Sarma MP; Polipalli SK; Begum N; Ahmad I; Khan LA; Husain SA; Akhtar N; Husain S; Thayumanavan L; Singla R; Kar P
    J Med Virol; 2010 Jul; 82(7):1115-25. PubMed ID: 20513073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.